Tralokinumab (IL13) - Research Grade Biosimilar
Product Specifications
Background
Tralokinumab is under investigation for the treatment of Alopecia Areata. Tralokinumab has been investigated for the treatment of Asthma.
Immunogen
Homo sapiens / IL13 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-lambda
NCBI Organism
Homo sapiens
Other Product Names
CAT-354
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7097201 Inquire
Recombinant Staphylococcus aureus Undecaprenyl-diphosphatase (uppP), partial
Sign In for Pricing
View Details 
MBS1235224-01 0.02 mg (E-Coli)
Recombinant Geobacter uraniireducens Ribonuclease HII (rnhB)
Sign In for Pricing
View Details MBS1235224-02 0.1 mg (E-Coli)
Recombinant Geobacter uraniireducens Ribonuclease HII (rnhB)
Sign In for Pricing
View Details 
MBS1235224-03 0.02 mg (Yeast)
Recombinant Geobacter uraniireducens Ribonuclease HII (rnhB)
Sign In for Pricing
View Details 
MBS1235224-04 0.1 mg (Yeast)
Recombinant Geobacter uraniireducens Ribonuclease HII (rnhB)
Sign In for Pricing
View Details MBS1235224-05 0.02 mg (Baculovirus)
Recombinant Geobacter uraniireducens Ribonuclease HII (rnhB)
Sign In for Pricing
View Details